Transfusional Iron Overload Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload - 2014
Terminated
Has Results
  • Transfusional Iron Overload
  • Beta-Thalassemia
  • Boston, Massachusetts
  • +8 more
2021-06-10
Jun 10, 2021
S
Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload - 2013
Completed
Has Results
  • Transfusional Iron Overload
  • Beta-thalassemia
  • SPD602 (FBS0701, SSP-004184)
  • Oakland, California
  • +8 more
2021-05-30
May 30, 2021
S
Treatment of Iron Overload Requiring Chelation Therapy
Withdrawn
  • Transfusional Iron Overload
  • +6 more
  • (no location specified)
2021-06-01
Jun 1, 2021
N
Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload - 2012
Completed
  • β-thalassemia
  • Transfusional Iron Overload
  • Cagliari, CA, Italy
  • +2 more
2020-12-06
Dec 6, 2020
N
A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in β-thalassemia Major Pediatric Patients With Transfusional Iron Overload. - 2008
Completed
Has Results
  • Transfusional Iron Overload
  • +2 more
  • Lyon, France
  • +3 more
2017-02-12
Feb 12, 2017
N
Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study - 2012
Terminated
Has Results
  • Myelodysplastic Syndrome
  • Transfusional Iron Overload
  • Caen, Cedex, France
  • +9 more
2017-03-01
Mar 1, 2017
N
A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity
Completed
  • Transfusional Iron Overload
  • Oakland, California
  • +17 more
2017-02-21
Feb 21, 2017
N
Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload - 2011
Completed
  • Hemoglobinopathies
  • +6 more
  • Adelaide, Australia
  • +3 more
2017-02-20
Feb 20, 2017
C
High-Tc Susceptometer to Monitor Transfusional Iron Overload - 2016
Completed
  • Transfusional Iron Overload
  • +4 more
  • Hepatic biomagnetic susceptibility measurement
  • New York, New York
    Columbia University Medical Center
2016-09-20
Sep 20, 2016
N
Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload - 2003
Completed
  • Transfusional Iron Overload
  • Cagliari, Italy
  • +3 more
2015-03-18
Mar 18, 2015
N
Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload - 2013
Completed
Has Results
  • Transfusional Iron Overload
  • Transfusional Hemosiderosis
  • Core Study: Deferasirox
  • +5 more
  • Toronto, Ontario, Canada
  • +20 more
2014-08-13
Aug 13, 2014
A
Active Drug Surveillance Program of Ferriprox Use - 2013
Completed
  • Transfusional Iron Overload
    • Nicosia, Cyprus
    • +13 more
    2013-04-19
    Apr 19, 2013
    F
    Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload
    Completed
    • Transfusional Iron Overload
    • Beta-thalassemia
    • Oakland, California
    • +4 more
    2012-02-08
    Feb 8, 2012